HIV Latency TORn Down

Mauro Giacca*

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

4 Citations (Scopus)


Combination therapy for HIV infection is effective at controlling disease but fails to eradicate the virus because a persistent reservoir of cells harbors latent HIV DNA. In this issue of Cell Host & Microbe, Besnard et al. (2016) show that the mTOR kinase is essential to reactivate HIV from latency.

Original languageEnglish
Pages (from-to)700-702
Number of pages3
JournalCell Host and Microbe
Issue number6
Publication statusPublished - 14 Dec 2016


  • HIV
  • latency
  • mTOR
  • therapy


Dive into the research topics of 'HIV Latency TORn Down'. Together they form a unique fingerprint.

Cite this